Nephrogenic diabetes insipidus

Seminars in Nephrology

Volumn 19, Issue 4, 1999, Pages 344-352

  Knoers, Nine V A M ^a,b   Monnens, Leo L A H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN; VASOPRESSIN V2 RECEPTOR;

ANTIDIURESIS; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; DIURESIS; GENE MUTATION; GENE THERAPY; HUMAN; KIDNEY TUBULE DISORDER; NEPHROGENIC DIABETES INSIPIDUS; PRIORITY JOURNAL; REVIEW; SODIUM RESTRICTION; X CHROMOSOME LINKED DISORDER;

AMINO ACID SEQUENCE; ANIMALS; DIABETES INSIPIDUS, NEPHROGENIC; FRAMESHIFT MUTATION; GENE THERAPY; HUMANS; KIDNEY TUBULES, COLLECTING; MOLECULAR SEQUENCE DATA; PROGNOSIS; RECEPTORS, VASOPRESSIN; VASOPRESSINS;

EID: 0032808560     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Mcllraith CH: Notes on some cases of diabetes insipidus with marked family and hereditary tendencies. Lancet ii:767-768, 1892
2. van Lieburg AF, Knoers NVAM, Monnens LAH: Clinical presentation and follow-up of thirty patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol, in press
3. Hoekstra JA, van Lieburg AF, Monnens LAH, et al: Cognitive and psychological functioning of patients with congential nephrogenic diabetes insipidus. Am J Hum Genet 61: 81-88, 1996
4. Sollner T, Whiteheart SW, Brunner M, et al: SNAP receptors implicated in vesicle targeting and fusion. Nature 362: 318-324, 1993
5. Nielsen S, Marples D, Brin H, et al: Expression of VAMP2-Iike proteins in kidney collecting duct intracellular vesicles. Colocalization with aquaporin-2 water channels. J Clin Invest 96:1834-1844, 1995
6. Frank! N, Macaluso F, Schubert W, et al: Water channel-carrying vesicles in the rat IMCD contain cellubrevin. Am J Physiol 269:C797-C801, 1995
7. Mandon B, Chou C-L, Nielsen S, et al: Syntaxin-4 is localized to the apical plasma membrane of rat collecting duct cells. Possible role in aquaporin-2 trafficking. J Clin Invest 98:906-913, 1996
8. Liebenhoff U, Rosenthal W: Identification of Rab3-, RabSa-, and synaptobrevin II-like proteins in a preparation of rat kidney vesicles containing the vasopressin-regulated water channel. FEES Lett 365:209-213, 1995
9. Holleran EA, Karki S, Holzbaur EL: The role of the dynactin complex in intracellular motility. Int Rev Cytol 182: 69-109, 1998
10. Pollock N, Koonce MP, de-Hostos EL, et al: In vitro microtubule-based organelle transport in wild-type Dictyostelium and cells overexpressing a truncated dynein heavy chain. Cell Motil Cytoskeleton 40:304-314, 1998
11. Marples D, Schroer TA, Ahrens N, et al: Dynein and dynactin colocalize with AQP2 water channels in intracellular vesicles from kidney collecting duct. Am J Physiol 274:F384-F394, 1998
12. Fushimi K, Sasaki S, Marumo F: Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel. J Biol Chem 272:14800-14804, 1997
13. Matsumura Y, Uchida S, Rai T, et al: Transcriptional regulation of aquaporin-2 water channel gene by cAMP. J Am Soc Nephrol 8:861-867, 1997
14. Ishibashi K, Sasaki S, Fushimi K, et al: Immunolocal-ization and effect of dehydration on AQP3, a basolateral water channel of kidney collecting ducts. Am J Physiol 271:F235-F241, 1997
15. Terris T, Ecelbarger CA, Marples D, et al: Distribution of aquaporin-4 water channel expression within rat kidney. Am J Physiol 269:F775-F785, 1995
16. Ecelbarger CA, Terris J, Frindt M, et al: Aquaporin-3 water channel localization and regulation in rat kidney. Am J Physiol 269:F663-F672, 1995
17. Ma T, Yang B, Gillespie A, et al: Generation and phenotype of a transgenic knockout mouse lacking the mercurialinsensitive water channel aquaporin-4. J Clin Invest 100:975-962, 1997
18. Hochberg Z, van Lieburg AF, Even L, et al: Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation. J Clin Endocrinol Metab 82:686-689, 1997
19. Mulders SM, Knoers NVAM, van Lieburg AF, et al: New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol 8:242-248, 1997
20. Lieburg van AF, Verdijk MAJ, Knoers NVAM, et al: Patients with autosomal recessive nephrogenic diabetes insipidus homozygous for mutations in the aquaporin-2 water channel gene. Am J Hum Genet 55:648-652, 1994
21. Deen PMT, Verdijk MAJ, Knoers NVAM, et al: Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264:92-95, 1994
22. Vargas-Poussou R, Forestier L, Dautzenberg MD, et al: Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 8:1855-1862, 1997
23. Bichet DG, Arthus M-F, Lonergan M, et al: Autosomal dominant and autosomal recessive nephrogenic diabetes insipidus: novel mutations in the AQP2 gene. J Am Soc Nephrol 6:717, 1995 (abstr)
24. Mulders SM, Bichet DG, Rijss JPL, et al: An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the golgi complex. J Clin Invest 102:57-66, 1998
25. Lieburg van AF, Knoers NVAM, Mallmann R, et al: Normal fibrinolytic responses to l-desamino-8-D-arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin-2 gene. Nephron 72:544-546, 1996
26. Knoers NVAM, van Os CH: Molecular and cellular defects in nephrogenic diabetes insipidus. Curr Opin Nephrol Hypertens 5:353-358, 1996
27. Bichet DG: Nephrogenic diabetes insipidus. Am J Med 105:431-442, 1998
28. Oksche A, Rosenthal W: The molecular basis of nephrogenic diabetes insipidus. J Mol Med 76:326-337, 1998
29. Jinnouchi H, Araki E, Miyamura N, et ai: Analysis of vasopressin receptor type II (V2R) gene in three Japanese pedigrees with congenital nephrogenic diabetes insipidus: identification of a family with complete deletion of the V2R gene. Eur J Endocrinol 134:689-698, 1996
30. Hoefsloot A, Verdijk M, Brunner H, et al: Identification of complete deletions of the AVPR2 gene in Nehprogenic diabetes insipidus. Am J Hum Genet 63:2114A, 1998 (abstr, suppl)
31. Wenkert D, Schoneberg T, Merendino JJ, et al: Functional characterization of five V2 vasopressin receptor gene mutations. Mol Cell Endocrinol 124:43-50, 1996
32. Sadeghi HM, Innamorati G, Birnbaumer M: An X-linked NDI mutation reveals a requirement for cell surface V2R expression. Mol Endocrinol 11:706-713, 1997
33. Oksche A, Dehe M, Schulein R, et al: Folding and cell surface expression of the vasopressin V2 receptor: requirement of the intracellular C-terminus. FEBS Lett 424:57-62, 1998
34. Tsukaguchi H, Matsubara H, Inada M: Expression studies of two vasopressin V2 receptor mutations, R202C and 804insG, in nephrogenic diabetes insipidus. Kidney Int 48:554562, 1995
35. Oschke A, Schulien R, Rutz C, et al: Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function. Mol Pharmacol 50:820-828, 1996
36. Tsakaguchi H, Matsubara H, Mon Y, et al: Two vasopressin type-2 receptor gene mutations R143P and 278delV in patients with nephrogenic diabetes insipidus impair ligand binding of the receptor. Biochem Biophys Res Commun 211:976-977, 1995
37. Birnbaumer M, Gilbert S, Rosenthal W: An extracellular congenital nephrogenic diabetes insipidus mutation in the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs adenylyl cyclase system. Mol Endocrinol 8:886-894, 1994
38. Sadeghi H, Robertson GL, Eichet DG, et al: Biochemical basis of partial nephrogenic diabetes insipidus. Mol Endocrinol 11:1806-1813, 1997
39. Betinnelli A, Albertazzi E, Barbier P, et al: Identification and functional analysis of new mutations in the vasopressin V2 receptor gene (V2R). J Am Soc Nephrol 9:16A, 1998 (abstr)
40. Faux MC, Scott JD: More on target with protein phosphorylation: conferring specificity by location. Trends Biochem Sei 12:312-315, 1996
41. Yokoyama K, Yamauchi A, Izumi M, et al: A lowaffinity vasopressin V2-receptor gene in a kindred with Xlinked nephrogenic diabetes insipidus. J Am Soc Nephrol 7:410-414, 1996
42. Lieburg van AF, Verdijk MAJ, Knoers NVAM, et al: In vitro-expression of mutations in the V2 receptor gene-confirmation of their role in the pathogenesis of X-linked nephrogenic diabetes insipidus. Pediatr Nephrol 8:C75, 1994 (abstr)
43. Pan Y, Wilson P, Gitschier J: The effect of eight V2 receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin. J Biol Chem 269:31933-31937, 1994
44. Rosenthal W, Antamarian A, Gilbert S, et al: A V2 vasopressin receptor unable to stimulate adenylyl cyclase. J Biol Chem 268:13030-13033, 1993
45. Tajima T, Nakae J, Takekoshi Y, et al: Three novel AVPR2 mutations in three Japanese families with X-linked nephrogenic diabetes insipidus. Pediatr Res 39:522-526, 1996
46. Lieburg van AF, Verdijk MAJ, Schoute F, et al: Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet 96:70-78, 1995
47. Nomura Y, Onigata K, Nagasima T, et al: Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab 82: 3434-3437, 1997
48. Eichet DG, Oschke AO, Rosenthal W: Congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 8:1951-1958, 1997
49. Canfield MC, Tamarappoo BK, Moses AM, et al: Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response. Hum Mol Genet 6:1865-1871, 1997
50. Kuwahara M: Aquaporin-2, a vasopressin-sensitive water channel, and nephrogenic diabetes insipidus. Intern Med 37:215-217, 1998
51. Oschke A, Moller A, Dickson J, et al: Two novel mutations in the aquaporin-2 and vasopressin V2 receptor genes in patients with nephrogenic diabetes insipidus. Hum Genet 98: 587-589, 1996
52. Deen PMT, Croes H, van Aubel, et al: Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest 95:2291-2296, 1995
53. Shinbo I, Fushimi K, Yamauchi Y, et al: Expression and analysis of AQP2 mutants causing nephrogenic diabetes insipidus in yeast vesicles. J Am Soc Nehprol 9:25A, 1998 (abstr)
54. Jung JS, Preston GM, Smith BL, et al: Molecular structure of the water channel through Aquaporin CHIP. The hourglass model. J Biol Chem 269:14648-14654, 1994
55. Deen PMT, Knoers NVAM: Physiology and pathophysiology of the aquaporin-2 water channel. Curr Opin Nephrol Hypertens 7:37-42, 1998
56. Tamarappoo BK, Verkman AS: Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaparones. J Clin Invest 101:2257-2267, 1998
57. Kamsteeg EJ, Wormhoudt TAM, van Os CH, et al: Tetramerization of AQP2-E258K with wild-type AQP2 explains dominant nephrogenic diabetes insipidus. J Am Soc Nephrol 9:20A, 1998 (abstr)
58. Kuwahara M, Iwai K, Uchida S, et al: A novel mutation on the aquaporin-2 (AQP2) gene causing autosomal dominant nephrogenic diabetes insipidus (NDI). J Am Soc Nephrol 9:390A, 1998 (abstr)
59. Bichet DG, Lonergan M, Arthus M-F, et al: The spectrum of nephrogenic diabetes insipidus mutations and importance of early recognition and treatment. J Am Soc Nephrol 9:386A, 1998 (abstr)
60. Knoers N, Monnens LAH: Amiloride-hydrochlorothiazide in the treatment of congenital nephrogenic diabetes insipidus. J Pediatr 117:499-502, 1990
61. Schoneberg T, Sandig V, Wess J, et al: Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication. J Clin Invest 100:1547-1556, 1997
62. Yun J, Schoneberg T, Wess J: Targeting of the vasopressin receptor in mice. Presented at the 1998 NDI foundation Global conference, La Jolla, California, March 2-4, 1998